Welcome to our dedicated page for Vext Science news (Ticker: VEXTF), a resource for investors and traders seeking the latest updates and insights on Vext Science stock.
Vext Science, Inc. (OTCQX: VEXTF) generates frequent news as a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Company news releases highlight developments across its cultivation, manufacturing and retail dispensary activities, as well as updates on its Vapen™ branded products and Herbal Wellness Center dispensaries.
On this page, readers can follow Vext’s announcements about financial results, including quarterly earnings releases that discuss revenue, EBITDA, Adjusted EBITDA and Cash Flow Margin, along with explanations of these non-IFRS financial measures. The company also issues notices about upcoming earnings calls and webcasts, providing details for investors who want to listen to management’s commentary.
Vext’s news flow often covers operational milestones in Ohio, such as regulatory approvals from the Ohio Division of Cannabis Control, the opening of new Herbal Wellness Center dispensaries, and progress on additional dual-use dispensary licenses under the 10(B) program. Updates describe the status of its Tier 1 cultivation facility, manufacturing facility and multiple dispensary locations in cities including Jackson, Columbus, Athens, Jeffersonville, Portsmouth and Fairfield.
Other news items may include corporate and capital markets disclosures, such as early warning reports by significant securityholders, changes in auditors, and voting results from annual general meetings. Together, these updates provide a detailed view of how Vext is operating its vertically integrated cannabis platform in its core states of Arizona and Ohio. Investors and followers of the cannabis sector can use this news feed to review VEXTF-related announcements and company statements in one place.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has expanded its engagement with Zuanic & Associates through a Revised Services Agreement. Under the new agreement, Zuanic will provide advisory, research, and investor relations services to Vext for an initial twelve-month term starting October 1, 2024. The services will be provided for a monthly cash fee not exceeding US$7,000. Zuanic, an arm's length financial consulting and research advisory firm based in New Jersey, will deliver these services through various mediums and platforms.
Vext Science (CSE: VEXT, OTCQX: VEXTF), a U.S.-based cannabis operator with operations in Arizona and Ohio, has distributed Meeting Materials for its upcoming Annual General Meeting scheduled for December 13, 2024. The materials include the Management Information Circular, Notice of Meeting, and proxy form. Due to the Canada Post strike, shareholders can access electronic copies through the company's website, SEDAR+ profile, or by email request. Registered shareholders must submit proxy forms 48 hours before the meeting, excluding weekends and holidays.
Vext Science reported Q3 2024 financial results with revenue of $9.0 million and Adjusted EBITDA of $2.9 million. The company saw a 14.2% sequential increase in consolidated retail sales, driven by adult-use sales growth in Ohio and market share gains in Arizona. Q3 performance showed significant improvement with Adjusted EBITDA margin reaching 32.0%, up from 12.9% in Q2 2024. The company is positioned to expand its Ohio footprint to reach the state dispensary license cap of 8, with new locations planned to open throughout 2025 and early 2026.
Vext Science (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has scheduled its Q3 2024 financial results release for November 21, 2024, before market open. The company will host a conference call and webcast on the same day at 8:00 a.m. ET. A replay of the conference call will be available until December 5, 2024, and the webcast will be accessible through Vext's investor website.
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has entered into a Services Agreement with PartnerCap Securities, The agreement, effective September 23, 2024, engages PartnerCap to provide services including Investor Relations Activities such as research and publication services.
The initial term of the agreement is six months, with automatic three-month renewals thereafter. Vext will pay PartnerCap a cash fee of US$18,000 for the initial term and US$9,000 for each subsequent three-month renewal. Additional fees may apply for services beyond Investor Relations Activities.
PartnerCap is a FINRA registered brokerage firm based in Bluffton, South Carolina, and operates at arm's length from Vext.
Vext Science (CSE: VEXT) (OTCQX: VEXTF) reported Q2 2024 financial results with revenue of $8.4 million and Adjusted EBITDA of $1.1 million. The company is well-positioned in Ohio's newly launched adult-use cannabis market, with a large footprint including a Tier 1 cultivation facility, manufacturing facility, and two retail dispensaries. Vext expects to reach the state dispensary license cap in 2024.
Key financial highlights:
- Q2 2024 revenue: $8,426,928
- Q2 2024 EBITDA: $171,309
- Q2 2024 Adjusted EBITDA margin: 12.9%
CEO Eric Offenberger noted the challenges in the consumer sector but expressed optimism about Ohio's adult-use market potential. The company is focusing on transitioning Ohio dispensaries to serve both medical and adult-use markets, enhancing Arizona operations, and exploring growth opportunities.
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, has announced plans to release its financial results for the second quarter ended June 30, 2024, before market open on August 20, 2024. The company will host a conference call and webcast on the same day at 08:00 a.m. ET.
Conference call details include:
- Date: August 20, 2024
- Time: 8:00 am E.T.
- Participant Dial-in: +1-647-484-8814 or 1-844-763-8274
- Conference ID: 10191819
A replay of the call and webcast will be available on Vext's investor website after the event.
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) has announced the commencement of adult-use cannabis sales in Ohio on August 6, 2024. The company has secured Certificates of Operation for dual licensing of its cultivation and manufacturing facility as well as its operated dispensaries in Jackson and Columbus. Vext's current footprint in Ohio includes a 25,000 square feet Tier 1 cultivation facility (expandable to 50,000 square feet), a manufacturing facility, and two operating dispensaries. The company has agreements for two additional dispensaries and is entitled to receive three more adult-use licenses as a Tier 1 Cultivator, potentially bringing its total retail footprint in Ohio to seven locations.
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) has secured dual-use Provisional Licenses from the Ohio Division of Cannabis Control for its cultivation and manufacturing facility, as well as its dispensaries in Jackson and Columbus. This marks a significant step towards obtaining Certificates of Operations, enabling Vext to enter Ohio's adult-use cannabis market.
Vext currently operates a Tier I cultivation facility, a manufacturing facility, and two dispensaries in Ohio. The company is set to expand its footprint with two additional dispensaries upon closing of the previously announced Ohio Expansion Transaction. CEO Eric Offenberger expressed optimism about the company's preparedness to leverage its position in the state for shareholder returns.
The company's Ohio footprint includes operational facilities in Jackson and Columbus, with plans for further expansion. An amendment to the Ohio Expansion Transaction has reduced the consideration from $9.4 million to $7.7 million.
Vext Science announced its Q1 2024 financial results, highlighting a revenue of $8.4 million, compared to $9.1 million in Q1 2023. The adjusted EBITDA stood at $1.9 million, a decrease from $2.9 million in Q1 2023. The EBITDA margin improved to 23.3% from 6.5% in Q4 2023. The company is preparing for the anticipated adult-use program in Ohio, leveraging its vertically-integrated operations. A $2 million standby credit facility has been secured to support operations and expansion in Ohio. CEO Eric Offenberger emphasized the potential growth in Ohio despite consumer challenges in Arizona. The company plans to enhance cash flow and shareholder returns with modest capital expenditures and strategic financial flexibility.
FAQ
What is the current stock price of Vext Science (VEXTF)?
What is the market cap of Vext Science (VEXTF)?
